Editorial

Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry

Volumn 8, Issue 2, 2008, Pages 103-104

  Morishita, Ryuichi ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITRIC OXIDE; PITAVASTATIN; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ANGIOCARDIOGRAPHY; ANTIOXIDANT ACTIVITY; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CONCENTRATION RESPONSE; CORONARY ARTERY OBSTRUCTION; DISEASE CONTROL; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; EDITORIAL; ENDOTHELIAL DYSFUNCTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; IC 50; ISCHEMIC HEART DISEASE; MAXIMUM PLASMA CONCENTRATION; OSTEOPOROSIS; OXIDATIVE STRESS; PLEIOTROPY; UNSTABLE ANGINA PECTORIS;

EID: 46649104485     PISSN: 18715222     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152208784587881     Document Type: Editorial

References (3)

1. Fuster, V.; Stein, B.; Ambrose, J.A.; Badimon, L.; Badimon, J.J.; Chesebro, J.H. Circulation, 1990, 82, II47-59.
2. Mundy, G.; Garrett, R.; Harris, S.; Chan, J.; Chen, D.; Rossini, G.; Boyce, B.; Zhao, M.; Gutierrez, G. Science, 1999, 286, 1946-9.
3. Morishita R, Tomita N, Ogibara T. FIMG-Co A reductase inhibitors in the treatment of cardiovascular diseases: stabilization of coronary artery plaque. Curr. Drug Targets, 2002, 3, 379-85.